Koyfin Home > Directory > Health Care > Adamas Pharma > Total Debt / Capital

Adamas Pharma Total Debt / Capital Chart (ADMS)

Adamas Pharma annual/quarterly Total Debt / Capital from 2012 to 2020.
  • Adamas Pharma Total Debt / Capital for the quarter ending June 06, 2020 was $122m a 28.25% increase of 34m year over year
  • Adamas Pharma Total Debt / Capital for the last 12 months ending June 06, 2020 was $122m a 28.25% increase of 34m year over year
  • Adamas Pharma Annual Total Debt / Capital for 2019 was $101m a 43.38% increase of 44m from 2018
  • Adamas Pharma Annual Total Debt / Capital for 2018 was $57m a -6.71% decrease of -4m from 2017
  • Adamas Pharma Annual Total Debt / Capital for 2017 was $61m a 77.95% increase of 47m from 2016
Other Ratios Metrics:
  • Adamas Pharma Other Liabilities for the quarter ending December 12, 2018 was $3m a 76.22% increase of 2m year over year
  • Adamas Pharma Total Debt / Equity for the quarter ending September 09, 2018 was $101m a -53.94% decrease of -54m year over year
View Chart On Koyfin

Quarterly ADMS Total Debt / Capital Data

06/2020$122m
03/2020$113m
12/2019$101m
09/2019$87m
06/2019$76m
03/2019$67m
12/2018$57m
09/2018$50m
06/2018$44m
03/2018$39m

Annual ADMS Total Debt / Capital Data

2019$101m
2018$57m
2017$61m
2012$13m